Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2016 Jul;117(1):17–20. doi: 10.1016/j.anai.2016.03.022

Table 1.

Monoclonal Antibodies in the Treatment of Pediatric Asthma

Name Therapeutic target Asthma phenotype/endotype Approved for use in children
Omalizumab IgE Atopic asthma/urban asthma Yes (≥12 years of age)
Mepolizumab IL-5 Eosinophilic asthma Yes (≥12 years of age)
Reslizumab IL-5 Eosinophilic asthma Under investigation
Lebrikizumab IL-13 Elevated periostin Under investigation
Tralokinumab IL-13 Eosinophilic asthma Under investigation

Abbreviation: IL, interleukin